What is the dead-space loss per draw with a 25G drawing needle at 3.33 mg/mL?

Concretely: a 25G drawing needle · 3.33 mg/mL.

Please show the division. I want to check my own against yours.

I would like the general form as well as the specific number, so I can apply it again.

Where is my error, and what is the correct working?

Dead space is the volume trapped in the syringe hub and needle after the plunger bottoms out, and it is the reason your 10 mg vial yields only 9.5 mg of usable draws.

Corollary that follows immediately: changing needle gauge or length barely changes your losses.

On the detail: be sceptical of anything advertised as low dead space that retains a conventional plunger tip: if you can look into the fitting with the plunger fully forward and see an open conical void, that void is your dead space.

Syringe residual volume has been measured properly, mainly in the infection-control literature, with a median residual of about 84 µL for a conventional 1 mL syringe with a detachable needle and roughly 2 µL for a fixed-needle low-dead-space design.

I would not underestimate the dead-space cost when calculating your true cost per dose.

If cost matters, this is the first thing to change, not the last.

The single most important fact about dead space is that it is almost entirely in the hub cone, not in the needle, which is why changing needle gauge or length barely changes your losses.

Configuration A — 1 mL luer-lock plus detachable needle, dead space 84 µL: each draw removes 100 + 84 = 184 µL. Draws available from 2,000 µL = 2000 / 184 = 10.87, so 10 full draws.

Low-dead-space syringe designs either have the needle bonded directly to the barrel — a fixed-needle syringe, which is the cheapest route — or add a moulded projection on the plunger tip that fills the luer cone.

The limitation is that even with perfect technique, some loss is irreducible unless you switch to a low-dead-space syringe.

Buy the right syringe — a fixed-needle insulin syringe is cheap and solves the problem.

A fixed-needle insulin syringe holds roughly 3 to 5 µL dead space and costs the same as a luer-lock syringe with 35 to 100 µL dead space.

The needle lumen volume is under a microlitre in a typical fine-gauge configuration, so the needle is not the problem.

The World Health Organisation guidance on injection equipment adopted the same high-versus-low dead-space distinction, using a low-dead-space threshold in the low single-digit microlitres.

The switch nearly doubles your vial, which is better than most other optimisations combined.

Changing syringe architecture changes everything, while changing needle gauge changes almost nothing.

The complete rule: fix the syringe architecture first, and then the reconstitution volume becomes a free choice you can make on stability grounds rather than on economics.

Worth noting: draw size matters enormously — the smaller your draws, the more the syringe architecture matters.

If cost matters, this is the first thing to change, not the last.